Cui Z D, LaScolea L J, Fisher J, Ogra P L
Department of Pediatrics, State University of New York, Buffalo.
Infect Immun. 1989 Mar;57(3):739-44. doi: 10.1128/iai.57.3.739-744.1989.
Groups of BALB/c mice were orally immunized with chlamydiae and challenged intranasally to determine whether oral immunization offers protection against pulmonary disease and to characterize the nature and kinetics of the chlamydial antibody response in the lung and other mucosal sites. Protection by oral immunization from chlamydial lung disease was demonstrated by lack of replication of the organism and the lack of chlamydial antigen in lung tissue. The chlamydial immunoglobulin A (IgA) antibody response was present at all body sites, reaching peak levels in the lung as well as in the serum. Classical IgA booster effect kinetics was observed after intranasal challenge, especially in the lung. Specific IgG antibody was detected at all body sites but at lower levels. Furthermore, animals immunized orally had no pneumonic process, as determined by histopathology. These studies also suggest that passively acquired specific serum IgG antibody may not significantly influence the course of mucosal replication of the organism. These observations indicate that oral immunization activating the gut-associated lymphoid tissue system gave total protection against chlamydial lung disease, suggesting migration of immunologically competent cells from the intestine to the lung.
将BALB/c小鼠分组,用衣原体进行口服免疫,然后进行鼻内攻毒,以确定口服免疫是否能提供针对肺部疾病的保护,并确定肺部和其他黏膜部位衣原体抗体反应的性质和动力学。口服免疫对衣原体肺部疾病的保护作用表现为肺部组织中病原体无复制且缺乏衣原体抗原。衣原体免疫球蛋白A(IgA)抗体反应在所有身体部位均有出现,在肺部以及血清中达到峰值水平。鼻内攻毒后观察到典型的IgA增强效应动力学,尤其是在肺部。在所有身体部位均检测到特异性IgG抗体,但水平较低。此外,通过组织病理学检查确定,口服免疫的动物没有肺炎病变过程。这些研究还表明,被动获得的特异性血清IgG抗体可能不会显著影响病原体在黏膜的复制过程。这些观察结果表明,激活肠道相关淋巴组织系统的口服免疫可提供针对衣原体肺部疾病的全面保护,提示免疫活性细胞从肠道迁移至肺部。